Dr. Matthew W Johnson

Yetter Coleman’s Matt Zorn chatted with none other than multi-awarded and great psychedelics researcher Dr. Matthew Johnson at Benzinga’s recently held Psychedelics Capital Conference. Dr. Matthew W. Johnson, Ph.D., is a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins....

Mydecine Innovations Group (NEO: MYCO) (OTCPINK: MYCOF) has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, to study the application of psychedelics molecules and therapies in smoking cessation. The research will be led by Dr. Matthew W. Johnson,...